PT Bundamedik Tbk

Jakarta Stock Exchange BMHS.JK

PT Bundamedik Tbk Net Income Margin for the year ending December 31, 2023: 0.50%

PT Bundamedik Tbk Net Income Margin is 0.50% for the year ending December 31, 2023, a -93.55% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

PT Bundamedik Tbk Net Income Margin for the year ending December 31, 2022 was 7.77%, a -57.83% change year over year.
PT Bundamedik Tbk Net Income Margin for the year ending December 31, 2021 was 18.43%, a 78.67% change year over year.
PT Bundamedik Tbk Net Income Margin for the year ending December 31, 2020 was 10.32%, a 217.89% change year over year.
PT Bundamedik Tbk Net Income Margin for the year ending December 31, 2019 was 3.25%, a 439.41% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Jakarta Stock Exchange: BMHS.JK

PT Bundamedik Tbk

CEO	Mr. Agus Heru Darjono
IPO Date	July 6, 2021
Location	Indonesia
Headquarters	Jl. Teuku Cik Ditiro No.28
Employees	1,434
Sector	Health Care
Industries Hospitals & Clinics

Description

PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.

Key trends

Past 5 years